Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Pantaleo

Showing results (1-10 of 341) with videos related to

Pageof 35
Sort By:
The Lancet. Infectious Diseases|December 7, 2007
HIV-1 T-cell vaccines: evaluating the next stepGiuseppe Pantaleo
European Journal of Immunology|August 18, 2005
Understanding what makes a good versus a bad vaccineAlexandre Harari, Giuseppe Pantaleo
Vaccine|June 20, 2008
A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell responseIsabelle Miconnet, Giuseppe Pantaleo
Nature Reviews. Immunology|April 20, 2006
Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseasesGiuseppe Pantaleo, Alexandre Harari
Advances in Pharmacology (San Diego, Calif.)|December 19, 2007
HIV-1-specific immune responseAlexandre Harari, Giuseppe Pantaleo
Current Opinion in HIV and AIDS|April 20, 2017
B-cell abnormalities and impact on antibody response in HIV infectionAlessandra Noto, Giuseppe Pantaleo
Endoscopy|September 27, 2016
Reply to Kadayifci and YildirimAlberto Mariani, Giuseppe Pantaleo
Current Opinion in HIV and AIDS|September 9, 2016
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm changeGiuseppe Pantaleo, Yves Levy
Current Opinion in HIV and AIDS|March 13, 2013
Vaccine and immunotherapeutic interventionsGiuseppe Pantaleo, Yves Lévy
Nature Medicine|August 3, 2004
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowGiuseppe Pantaleo, Richard A Koup
Pageof 35

Showing results (1-10 of 341) with videos related to

Sort By:
Pageof 35
The Lancet. Infectious Diseases|December 7, 2007
HIV-1 T-cell vaccines: evaluating the next stepGiuseppe Pantaleo
European Journal of Immunology|August 18, 2005
Understanding what makes a good versus a bad vaccineAlexandre Harari, Giuseppe Pantaleo
Vaccine|June 20, 2008
A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell responseIsabelle Miconnet, Giuseppe Pantaleo
Nature Reviews. Immunology|April 20, 2006
Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseasesGiuseppe Pantaleo, Alexandre Harari
Advances in Pharmacology (San Diego, Calif.)|December 19, 2007
HIV-1-specific immune responseAlexandre Harari, Giuseppe Pantaleo
Current Opinion in HIV and AIDS|April 20, 2017
B-cell abnormalities and impact on antibody response in HIV infectionAlessandra Noto, Giuseppe Pantaleo
Endoscopy|September 27, 2016
Reply to Kadayifci and YildirimAlberto Mariani, Giuseppe Pantaleo
Current Opinion in HIV and AIDS|September 9, 2016
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm changeGiuseppe Pantaleo, Yves Levy
Current Opinion in HIV and AIDS|March 13, 2013
Vaccine and immunotherapeutic interventionsGiuseppe Pantaleo, Yves Lévy
Nature Medicine|August 3, 2004
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowGiuseppe Pantaleo, Richard A Koup
Pageof 35